Mark Tepper - Net Worth and Insider Trading

Mark Tepper Net Worth

The estimated net worth of Mark Tepper is at least $1 Million dollars as of 2024-11-13. Mark Tepper is the President and CSO of Corbus Pharmaceuticals Holdings Inc and owns about 69,967 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $1 Million. Details can be seen in Mark Tepper's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Tepper has not made any transactions after 2014-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Tepper

To

Mark Tepper Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Tepper owns 2 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) , and LadRx Corp (LADX) .

Click here to see the complete history of Mark Tepper’s form 4 insider trades.

Insider Ownership Summary of Mark Tepper

Ticker Comapny Transaction Date Type of Owner
CRBP Corbus Pharmaceuticals Holdings Inc 2014-11-24 President and CSO
LADX LadRx Corp 2004-05-06 Vice President

Mark Tepper Latest Holdings Summary

Mark Tepper currently owns a total of 1 stock. Mark Tepper owns 69,967 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of November 24, 2014, with a value of $1 Million.

Latest Holdings of Mark Tepper

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRBP Corbus Pharmaceuticals Holdings Inc 2014-11-24 69,967 17.94 1,255,208

Holding Weightings of Mark Tepper


Mark Tepper Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Tepper has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the sale of 0 shares on November 24, 2014, which brought Mark Tepper around $0.

Insider Trading History of Mark Tepper

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Tepper Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Tepper Ownership Network

Ownership Network List of Mark Tepper

No Data

Ownership Network Relation of Mark Tepper

Insider Network Chart

Mark Tepper Owned Company Details

What does Corbus Pharmaceuticals Holdings Inc do?

Who are the key executives at Corbus Pharmaceuticals Holdings Inc?

Mark Tepper is the President and CSO of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .

Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary

Over the past 18 months, Mark Tepper made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , a net purchase of 900,000 shares made by Cormorant Asset Management, Lp , and a net sale of 63,358 shares made by Yuval Cohen .

In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 350,000 shares, with a net purchase of 350,000 shares. During the past 18 months, 81,401 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,932,632 shares were bought by its insiders, resulting in a net purchase of 1,851,231 shares.

Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corbus Pharmaceuticals Holdings Inc Insider Transactions

No Available Data

Mark Tepper Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Tepper. You might contact Mark Tepper via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.